SCHEMBL4552082

SCHEMBL4552082

C1=C2CC(=C1)c1ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.38
ALDH1A1 P00352 4/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CDC25B P30305 2/20 0.35
CES1 P23141 3/20 0.35
BCHE P06276 2/20 0.35
MAPK1 P28482 3/20 0.33
TDP2 O95551 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CES2 O00748 1/20 0.33
APAF1 O14727 1/20 0.33
TERT O14746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7392371 1.00 MAOA (0.38) MAOAALDH1A1NPC1SMN1; SMN2KDM4E
Benzene SCHEMBL29018627 0.75 ALDH1A1 (0.41) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL8909389 0.73 MEN1 (0.50) MAOAALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL3982745 0.71 ALDH1A1 (0.47) ALDH1A1NPC1KDM4ELMNAMAPT
SCHEMBL15364115 0.70 PTPRC (0.45) MAOAALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL15364118 0.70 PTPRC (0.45) MAOAALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL3302659 0.65 MAOA (0.48) MAOAALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL49870 0.64 MEN1 (0.61) MAOAALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL11875421 0.64 MEN1 (0.61) MAOAALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL58152 0.64 MEN1 (0.61) MAOAALDH1A1NPC1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595359-B2 Resin composition for forming optical component, molded product, and optical component MITSUI CHEMICALS, INC. (JP) 2026-04-07 US disclosed
US-12441823-B2 Resin composition for optical shaping KURARAY NORITAKE DENTAL INC. (JP) 2025-10-14 US disclosed
US-20250206930-A1 RECYCLED CYCLIC OLEFIN RESIN COMPOSITION, MOLDED BODY, OPTICAL COMPONENT, AND METHOD FOR PRODUCING RECYCLED CYCLIC OLEFIN RESIN COMPOSITION MITSUI CHEMICALS, INC. (JP) 2025-06-26 US disclosed
EP-4502051-A1 RECYCLED CYCLIC OLEFIN RESIN COMPOSITION, MOLDED BODY, OPTICAL COMPONENT, AND METHOD FOR MANUFACTURING RECYCLED CYCLIC OLEFIN RESIN COMPOSITION Mitsui Chemicals, Inc. (JP) 2025-02-05 EP disclosed
WO-2025023210-A1 RESIN COMPOSITION, LENS, LIGHT-TRANSMITTING FILTER, OPTICAL MEMBER, AND IMAGING CAMERA 三井化学株式会社 2025-01-30 WO disclosed
WO-2024203631-A1 PREPARATION IN CONTAINER, AND PACKAGING 三井化学株式会社 2024-10-03 WO disclosed
CN-118632896-A Regenerated cycloolefin resin composition, molded article, optical member, and method for producing regenerated cycloolefin resin composition 三井化学株式会社 2024-09-10 CN disclosed
CN-118530436-A Hydrogenated cycloolefin polymer and preparation method and application thereof 万华化学集团股份有限公司 2024-08-23 CN disclosed
US-12030970-B2 Curable composition and stereolithographic resin composition comprising same KURARAY CO., LTD. (JP) 2024-07-09 US disclosed
WO-2024127999-A1 METHOD FOR PRODUCING CYCLIC OLEFIN COMPOUND 三井化学株式会社 2024-06-20 WO disclosed
EP-3971237-A1 RESIN COMPOSITION FOR OPTICAL COMPONENT, MOLDED ARTICLE, AND OPTICAL COMPONENT Mitsui Chemicals, Inc. (JP) 2022-03-23 EP disclosed
CN-114072439-A Curable composition and resin composition for stereolithography comprising same 株式会社可乐丽 2022-02-18 CN disclosed
US-20220041777-A1 RESIN COMPOSITION FOR OPTICAL SHAPING KURARAY NORITAKE DENTAL INC. (JP) 2022-02-10 US disclosed
CN-113993497-A Curable composition and resin composition for stereolithography comprising same 株式会社可乐丽 2022-01-28 CN disclosed
WO-2020129736-A1 RESIN COMPOSITION FOR OPTICAL MOLDING クラレノリタケデンタル株式会社 2020-06-25 WO disclosed
EP-3596195-A1 BENEFIT AGENT CONTAINING DELIVERY PARTICLE The Procter and Gamble Company (US) 2020-01-22 EP disclosed
WO-2018169532-A1 BENEFIT AGENT CONTAINING DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2018-09-20 WO disclosed
WO-2014017618-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM USING THE SAME, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE AND ELECTRONIC DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2014-01-30 WO disclosed
US-7501154-B2 Surface modification of CVD polymer films RENSSELAER POLYTECHNIC INSTITUTE (US) 2009-03-10 US disclosed
US-20050227055-A1 Surface modification of CVD polymer films RENSSELAER POLYTECHNIC INSTITUTE (US) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595359-B2 Resin composition for forming optical component, molded product, and optical component ASIC1, NLRP1, ASIC3 MAOA 3616/4885ALDH1A1 744/4885NPC1 3961/4885
US-12030970-B2 Curable composition and stereolithographic resin composition comprising same ARL1, ASH2L, VCL MAOA 3451/4885ALDH1A1 1097/4885NPC1 4837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.